These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 23765676)

  • 1. Tumor targeting by a carbohydrate ligand-mimicking peptide.
    Hatakeyama S; Shibata TK; Tobisawa Y; Ohyama C; Sugihara K; Fukuda MN
    Methods Mol Biol; 2013; 1022():369-86. PubMed ID: 23765676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted drug delivery to tumor vasculature by a carbohydrate mimetic peptide.
    Hatakeyama S; Sugihara K; Shibata TK; Nakayama J; Akama TO; Tamura N; Wong SM; Bobkov AA; Takano Y; Ohyama C; Fukuda M; Fukuda MN
    Proc Natl Acad Sci U S A; 2011 Dec; 108(49):19587-92. PubMed ID: 22114188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbohydrate mimetic peptides as research reagent and therapeutic.
    Fukuda MN; Hatakeyama S; Sugihara K
    Biol Pharm Bull; 2012; 35(10):1626-32. PubMed ID: 23037151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an orally-administrable tumor vasculature-targeting therapeutic using annexin A1-binding D-peptides.
    Nonaka M; Mabashi-Asazuma H; Jarvis DL; Yamasaki K; Akama TO; Nagaoka M; Sasai T; Kimura-Takagi I; Suwa Y; Yaegashi T; Huang CT; Nishizawa-Harada C; Fukuda MN
    PLoS One; 2021; 16(1):e0241157. PubMed ID: 33406123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retro-inverso carbohydrate mimetic peptides with annexin1-binding selectivity, are stable in vivo, and target tumor vasculature.
    Chen X; Fan Z; Chen Y; Fang X; Sha X
    PLoS One; 2013; 8(12):e80390. PubMed ID: 24312470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomography imaging of a novel Anxa1-targeted peptide
    Chen F; Xiao Y; Shao K; Zhu B; Jiang M
    J Labelled Comp Radiopharm; 2020 Oct; 63(12):494-501. PubMed ID: 32562502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparan sulfate binds the extracellular Annexin A1 and blocks its effects on pancreatic cancer cells.
    Belvedere R; Novizio N; Pessolano E; Tosco A; Eletto D; Porta A; Campiglia P; Perretti M; Filippelli A; Petrella A
    Biochem Pharmacol; 2020 Dec; 182():114252. PubMed ID: 32998001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-targeting peptide conjugated pH-responsive micelles as a potential drug carrier for cancer therapy.
    Wu XL; Kim JH; Koo H; Bae SM; Shin H; Kim MS; Lee BH; Park RW; Kim IS; Choi K; Kwon IC; Kim K; Lee DS
    Bioconjug Chem; 2010 Feb; 21(2):208-13. PubMed ID: 20073455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent retro-inverso D-peptide for simultaneous targeting of angiogenic blood vasculature and tumor cells.
    Li Y; Lei Y; Wagner E; Xie C; Lu W; Zhu J; Shen J; Wang J; Liu M
    Bioconjug Chem; 2013 Jan; 24(1):133-43. PubMed ID: 23241015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective tumor targeting and enhanced anti-tumor effect of liposomes engrafted with peptides specific for tumor lymphatics and vasculature.
    Herringson TP; Altin JG
    Int J Pharm; 2011 Jun; 411(1-2):206-14. PubMed ID: 21443937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. targeted drug delivery to hepatocarcinoma in vivo by phage-displayed specific binding peptide.
    Du B; Han H; Wang Z; Kuang L; Wang L; Yu L; Wu M; Zhou Z; Qian M
    Mol Cancer Res; 2010 Feb; 8(2):135-44. PubMed ID: 20145035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of phage display and molecular grafting generates highly specific tumor-targeting miniproteins.
    Zoller F; Markert A; Barthe P; Zhao W; Weichert W; Askoxylakis V; Altmann A; Mier W; Haberkorn U
    Angew Chem Int Ed Engl; 2012 Dec; 51(52):13136-9. PubMed ID: 23150222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting of tumor blood vessels: a phage-displayed tumor-homing peptide specifically binds to matrix metalloproteinase-2-processed collagen IV and blocks angiogenesis in vivo.
    Mueller J; Gaertner FC; Blechert B; Janssen KP; Essler M
    Mol Cancer Res; 2009 Jul; 7(7):1078-85. PubMed ID: 19584266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential role of Anxa1 in cancer.
    Guo C; Liu S; Sun MZ
    Future Oncol; 2013 Nov; 9(11):1773-93. PubMed ID: 24156336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proresolving and tissue-protective actions of annexin A1-based cleavage-resistant peptides are mediated by formyl peptide receptor 2/lipoxin A4 receptor.
    Dalli J; Consalvo AP; Ray V; Di Filippo C; D'Amico M; Mehta N; Perretti M
    J Immunol; 2013 Jun; 190(12):6478-87. PubMed ID: 23686496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Annexin-1 interacts with NEMO and RIP1 to constitutively activate IKK complex and NF-κB: implication in breast cancer metastasis.
    Bist P; Leow SC; Phua QH; Shu S; Zhuang Q; Loh WT; Nguyen TH; Zhou JB; Hooi SC; Lim LH
    Oncogene; 2011 Jul; 30(28):3174-85. PubMed ID: 21383699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Annexin A1 localization and its relevance to cancer.
    Boudhraa Z; Bouchon B; Viallard C; D'Incan M; Degoul F
    Clin Sci (Lond); 2016 Feb; 130(4):205-20. PubMed ID: 26769657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers.
    Luthra R; Singh RR; Luthra MG; Li YX; Hannah C; Romans AM; Barkoh BA; Chen SS; Ensor J; Maru DM; Broaddus RR; Rashid A; Albarracin CT
    Oncogene; 2008 Nov; 27(52):6667-78. PubMed ID: 18663355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-inflammatory mechanisms of the annexin A1 protein and its mimetic peptide Ac2-26 in models of ocular inflammation in vivo and in vitro.
    Girol AP; Mimura KK; Drewes CC; Bolonheis SM; Solito E; Farsky SH; Gil CD; Oliani SM
    J Immunol; 2013 Jun; 190(11):5689-701. PubMed ID: 23645879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TMTP1, a novel tumor-homing peptide specifically targeting metastasis.
    Yang W; Luo D; Wang S; Wang R; Chen R; Liu Y; Zhu T; Ma X; Liu R; Xu G; Meng L; Lu Y; Zhou J; Ma D
    Clin Cancer Res; 2008 Sep; 14(17):5494-502. PubMed ID: 18765541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.